Fetal Brain Asymmetry: in Utero and Early Neonatal Follow up

This study has been terminated.
(Difficulties in recruiting)
Sponsor:
Information provided by (Responsible Party):
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT01707875
First received: October 14, 2012
Last updated: June 14, 2015
Last verified: July 2012

October 14, 2012
June 14, 2015
November 2012
July 2014   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01707875 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Fetal Brain Asymmetry: in Utero and Early Neonatal Follow up
Not Provided

Fetal brain asymmetry is considered a normal developmental processes. The size and shape of the lateral ventricles are interdependence with the brain parenchyma. Abnormal development of the fetal brain may cause unilateral or bilateral ventriculomegaly. Fetal cerebral ventricle measurement is one of the most frequently used sonographic tool for the evaluation of brain development. It is easier to evaluate and measure the distal cerebral ventricle, and therefore data concerning the normal range of asymmetry and the normal progress of the asymmetry are limited.

The objective of the study is to follow up the incidental finding of fetal ventricle brain asymmetry between 19-30 weeks of pregnancy.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Pregnant women with fetal ventricle brain asymmetry

Fetal Ventricle Brain Asymmetry
Other: fetal brain neurosonography
fetal brain neurosonography according to the ISUG guidelines
fetal ventricle brain asymmetry
Intervention: Other: fetal brain neurosonography
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
6
July 2014
July 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18-42 years old pregnant women
  • 19-30 weeks of pregnancy
  • No medical history of chronic disease
  • No medical history of drug therapy
  • No other findings on ultrasound examination
  • Low risk pregnancy

Exclusion Criteria:

  • Fetal malformation
  • Chronic maternal disease
  • Fetal chromosomal aberration
  • suspected fetal infection
Female
18 Years to 42 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01707875
EMC-0062-12-CTIL
No
HaEmek Medical Center, Israel
HaEmek Medical Center, Israel
Not Provided
Not Provided
HaEmek Medical Center, Israel
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP